掌閲科技(603533.SH):iReader閲讀器是深圳市掌閲科技的產品,其已剝離出上市公司
格隆匯4月28日丨有投資者在投資者互動平台向掌閲科技(603533.SH)提問,“貴司iReader閲讀器可以接入大模型以實現更智能的交互體驗嗎?貴司有沒有打算開發其他的基於人工智能的交互產品?”
掌閲科技回覆稱,(1)公司將利用公司在數據、場景、用户等方面的優勢,不斷提升用户的閲讀體驗,從數字閲讀升級至智能閲讀;加快AI 大模型在數字閲讀垂直領域的調優工作,推動 AIGC 在內容生產、營銷推廣、豐富產品形態等多方面深化應用。(2)iReader閲讀器是深圳市掌閲科技有限公司的產品,深圳市掌閲科技有限公司已於2019年3月剝離出了上市公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.